Multiple Sclerosis Center of Atlanta — Atlanta, Georgia

Multiple Sclerosis Center of Atlanta is a clinical research site located in Atlanta, Georgia, United States 30327.

Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.

Multiple Sclerosis Center of Atlanta has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Alzheimer's Disease, Multiple Sclerosis, Relapsing-Remitting.

Sponsors: Georgia State University, JANSSEN Alzheimer Immunotherapy Research & Development, LLC, Mallinckrodt ARD LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Atlanta

Browse all research sites in Georgia · View every site in Atlanta

Sponsor Feasibility Report

Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Multiple Sclerosis Center of Atlanta?

Multiple Sclerosis Center of Atlanta has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Multiple Sclerosis Center of Atlanta conducted?

Multiple Sclerosis Center of Atlanta has 4 clinical trials on record, with 1 currently active. Their work covers Relapsing Multiple Sclerosis, Alzheimer's Disease, Multiple Sclerosis, Relapsing-Remitting.

Is Multiple Sclerosis Center of Atlanta accredited by Crixeo Clinical Trials?

Multiple Sclerosis Center of Atlanta has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Multiple Sclerosis Center of Atlanta?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.